PTSD Trial, Recruiting NCT07644338 Sponsor: Shanghai Mental Health Center Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT07644338
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 50 years old (male or female)
  • You have been diagnosed with PTSD according to standard diagnostic guidelines, your symptoms have lasted at least 3 months, and PTSD is your main current diagnosis (having depression or an anxiety disorder alongside PTSD is allowed)
  • If you are currently taking psychiatric medication, your dose has been the same for at least 4 weeks before joining
  • You have completed at least 9 years of education (junior high school level or higher)

Who may not be able to join:

  • You have a mental health diagnosis other than PTSD, depression, or an anxiety disorder
  • Your PTSD symptoms are so severe that completing the required study assessments would not be possible
  • You have had electroconvulsive therapy (ECT), a type of brain stimulation treatment, in the past 6 months
  • You have had any other type of brain stimulation treatment in the past 2 months
  • You have a serious physical illness, or any condition that could cause seizures or increased pressure in the brain (such as significant heart or lung disease)
  • You have a history of neurological conditions (such as epilepsy or stroke) or have had a brain injury or brain surgery
  • You have metal implants in your head, a pacemaker, coronary stents, cochlear implants, or any other implants that are not safe for MRI scans
  • The study team has assessed that you are currently at significant risk of suicidal behaviour
  • You are pregnant or planning to become pregnant during the study
  • You recently started a structured therapy programme specifically for PTSD (within the past 3 months) and it is expected to change during the 10-week treatment period (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 34773516

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Mental Health Center
Registry
ClinicalTrials.gov
Start date
8 June 2026
Est. completion
1 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

post-traumatic stress disorder symptoms improvement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov